Literature DB >> 2304284

A proposal of indices to describe the carcinoembryonic antigen time course in in order to assess the effects of treating recurrent colo-rectal carcinoma.

T Iwama1, Y Mishima, H Sato.   

Abstract

In order to assess the effects of treating recurrent or non-resectable colo-rectal cancer, the following 5 indices for the serum CEA time course were devised: 1. If the serum CEA doubling time is altered by any treatment from D1 to D2 we term D2/D1 as the "CEA doubling time ratio" of the treatment; 2. the per cent decrease in the serum CEA level from CEA1 to CEA2 is calculated by (logCEA1 - logCEA2) X 100/logCEA1; 3. the period when the CEA level has returned to normal after a treatment is termed the "normalization period"; 4. "backward time retrieval" is the period between the lowest point of the posttreatment CEA and the crossing-point of this level by the pretreatment rising slope and; 5. "forward time earning" can also be defined. By using these indices, surgical treatments resulted in a higher per cent decrease in CEA, a longer normalization period but a shorter doubling time when the tumor recurred.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2304284     DOI: 10.1007/bf02470726

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  7 in total

1.  [Growth rate of human colorectal cancer xenografted in nude mice].

Authors:  K Yamada; S Takao; T Ishizawa; H Shimazu
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1987-02

2.  Slope analysis of the postoperative CEA time course and its possible application as an aid in diagnosis of disease progression in gastrointestinal cancer.

Authors:  H J Staab; F A Anderer; E Stumpf; R Fischer
Journal:  Am J Surg       Date:  1978-09       Impact factor: 2.565

3.  Detection of recurrence of large-bowel carcinoma by radioimmunoassay of circulating carcinoembryonic antigen (C.E.A.).

Authors:  J P Mach; P Jaeger; M M Bertholet; C H Ruegsegger; R M Loosli; J Pettavel
Journal:  Lancet       Date:  1974-09-07       Impact factor: 79.321

4.  Significance of a fall in serum CEA concentration in patients treated with cytotoxic chemotherapy for disseminated colorectal cancer.

Authors:  T G Allen-Mersh; N Kemeny; D Niedzwiecki; B Shurgot; J M Daly
Journal:  Gut       Date:  1987-12       Impact factor: 23.059

5.  Circulating tumor markers and assessment of response to intrahepatic chemotherapy of colon carcinoma.

Authors:  H F Sears; J W Shen; M Herlyn; B Atkinson; P F Engstrom; H Koprowski
Journal:  Am J Clin Oncol       Date:  1985-04       Impact factor: 2.339

6.  [Carcinoembryonic antigen: diagnosis and tumor progression in gastrointestinal tumors].

Authors:  T Brümmendorf; F A Anderer; H J Staab; A Hornung; G Kieninger
Journal:  Dtsch Med Wochenschr       Date:  1985-12-20       Impact factor: 0.628

7.  Doubling time of circulating cea and its relation to survival of patients with recurrent colorectal cancer.

Authors:  H J Staab; F A Anderer; A Hornung; E Stumpf; R Fischer
Journal:  Br J Cancer       Date:  1982-11       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.